Josiah D. Land

Immunophenotype and Response to Immunotherapy of <i>RET</i>-Rearranged Lung Cancers

Michael Offin, Robin Guo, Stephanie L. Wu et al. · JCO Precision Oncology · 2019 · 117 citations · Full text

Medicine, Oncology, Pharmacology +17

Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers

Yonina R. Murciano‐Goroff, Terry Pak, Sebastián Mondaca et al. · British Journal of Cancer · 2021 · 26 citations · Full text

Medicine, Immunology, Oncology +14

P1.04-39 Molecular Characteristics, Immunophenotype, and Immune Checkpoint Inhibitor Response in BRAF Non-V600 Mutant Lung Cancers

Michael Offin, Terry Pak, Sebastián Mondaca et al. · Journal of Thoracic Oncology · 2019 · 15 citations

Medicine, Molecular Genetics, Oncology +16

Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City

Prakirthi Yerram, Jennifer Thackray, Lisa Modelevsky et al. · Journal of Oncology Pharmacy Practice · 2021 · 14 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacy Practice +8

<i>RET</i>-rearranged lung cancers: Immunophenotype and response to immunotherapy.

Joshua K. Sabari, Michael Offin, Stephanie L. Wu et al. · Journal of Clinical Oncology · 2018 · 12 citations

Medicine, Immunology, Oncology +17